Most of what got written about all-payer OASIS was explainer content published before agencies actually had to live with it. Even now, some agencies think they don’t need to be worried about doing QA on Medicare Advantage. What the mandate requires, which patients it covers, when the deadline hits. That content served its purpose at the time, but it's not much use anymore, because the real question now isn't what the rule says. It's what agencies are actually getting wrong now that they've been living under it.

Here's what that looks like from where we sit.

The volume problem showed up first

The most immediate thing agencies ran into wasn't a documentation quality problem, it was a sheer volume problem. Extending OASIS collection to every patient regardless of payer meant a real jump in the number of assessments clinicians and QA teams have to complete and review, on top of everything they were already doing. Agencies that had quietly used a shortened or informal version of OASIS for non Medicare patients before the mandate suddenly had a much bigger, much less familiar workload to manage well.

Volume problems tend to create quality problems downstream, and that's exactly what's started showing up.

Where the actual errors are clustering

The clearest pattern is inconsistent functional scoring on patients who were previously outside the traditional Medicare, PDGM focused workflow. Clinicians who spent years getting fast, specific feedback on Medicare OASIS accuracy are now applying the same assessment to a population they have less institutional muscle memory with, and the GG scoring inconsistencies that used to get caught quickly on the Medicare side are slipping through more often on this expanded population. A recent industry guide on OASIS-E documentation points to this same pattern, noting that the most consistent documentation failures right now are showing up in functional scoring, M-item completion, and narrative-to-code alignment, and that these are clinical judgment gaps rather than simple data entry mistakes.

There's also a documentation completeness gap, particularly around items agencies previously treated as lower priority for non Medicare patients. Fields that used to get a quick, minimal answer under the old informal approach are now expected to hold up to the same standard as a Medicare assessment, and that expectation hasn't fully caught up with practice yet on a lot of charts.

And then there's the timing problem. All payer OASIS didn't just add more assessments, it added them across patients with different intake workflows, different referral sources, and different documentation habits built up over years of those patients being treated differently. Getting those assessments completed within the same compliance windows agencies already had to hit for Medicare patients has been a bigger lift than most agencies expected going in.

Why this matters more than a compliance footnote

These aren't small issues. Functional scoring feeds directly into case mix and into HHVBP's functional outcome measures, both of which increasingly depend on OASIS data across an agency's full census, not just its traditional Medicare population. A recent breakdown of the CY 2026 Final Rule reinforces why the timing here matters, since larger-volume agencies are now scored under a 40 percent OASIS-based, 40 percent claims-based, 20 percent patient experience weighting, and treating all-payer OASIS as anything less than fully in place across every branch and payer type is flagged there as a direct compliance gap, not a minor detail.

Agencies that treated the all-payer mandate purely as a compliance deadline to hit, rather than a real expansion of their QA workload, are the ones most likely to be sitting on accumulated scoring drift right now without a clear picture of how much.

What's actually worth doing at this point

If your OASIS QA process was built around Medicare volume, it's worth a hard look at whether it's genuinely scaled to your full census or is just running the same review capacity across a bigger number of charts. Pulling a sample specifically from your non traditional payer population and comparing it against your historical Medicare accuracy rates will usually tell you quickly whether a real gap has opened up.

The agencies handling this well are the ones partnering with tech forward vendors that are able to deliver both high quality and faster turnaround times that ensures the agencies’ ability to keep up with “All Payer” and “OASIS QA” volume increases.

See where your own data stands

We offer a 30-day, low-risk pilot, opt out any time, so you can see firsthand how your full payer mix holds up, along with the speed and accuracy of our review and the quality of our support.